MIST — Milestone Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $81.50m
- $49.78m
- $1.00m
- 18
- 13
- 30
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -55.2 | -50 | -42.9 | -58.4 | -59.7 |
Depreciation | |||||
Non-Cash Items | 1.19 | 4.95 | 7.28 | 9.09 | 11.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.85 | -5.81 | 2.26 | -3.26 | 1.24 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -51.2 | -50.7 | -33.2 | -52.5 | -46.4 |
Capital Expenditures | -0.413 | — | — | -0.272 | -0.112 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.029 | -70 | 70 | -56.9 | 4.87 |
Acquisition of Business | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.384 | -70 | 70 | -57.1 | 4.76 |
Financing Cash Flow Items | — | — | — | — | -2.79 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 85.4 | 73.2 | 5.05 | 3.09 | 47.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 33.9 | -47.5 | 41.8 | -107 | 6.12 |